Total Payments
$440.60
2020 Payments
$64.26
Companies
5
Transactions
26
Medicare Patients
794
Medicare Billing
$119,868
Payment Breakdown by Category
Food & Beverage$440.60 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $440.60 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $188.85 | 12 | $0 (2019) |
| Alkermes, Inc. | $165.13 | 8 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $46.14 | 3 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $29.03 | 2 | $0 (2020) |
| Lundbeck LLC | $11.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $64.26 | 3 | Alkermes, Inc. ($49.26) |
| 2019 | $150.78 | 8 | Alkermes, Inc. ($95.44) |
| 2018 | $79.48 | 5 | Janssen Pharmaceuticals, Inc ($68.03) |
| 2017 | $146.08 | 10 | Janssen Pharmaceuticals, Inc ($65.48) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: CNS | ||||||
| 03/02/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/11/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: CNS | ||||||
| 11/13/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: CNS | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Neuroscience | ||||||
| 07/23/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Neuroscience | ||||||
| 06/13/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: CNS | ||||||
| 06/13/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Neuroscience | ||||||
| 05/07/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: CNS | ||||||
| 04/04/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: CNS | ||||||
| 02/19/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: CNS | ||||||
| 12/17/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Neuroscience | ||||||
| 11/14/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Neuroscience | ||||||
| 07/16/2018 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.45 | General |
| Category: PSYCHIATRY | ||||||
| 04/18/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Neuroscience | ||||||
| 01/30/2018 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Neuroscience | ||||||
| 09/13/2017 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: CNS | ||||||
| 08/08/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Neuroscience | ||||||
| 07/27/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: CNS | ||||||
| 06/13/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Neuroscience | ||||||
| 05/01/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Neuroscience | ||||||
| 04/18/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: CNS | ||||||
| 04/03/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Neuroscience | ||||||
| 03/08/2017 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 82 | 240 | $43,071 | $14,681 |
| 2022 | 7 | 196 | 396 | $74,614 | $25,964 |
| 2021 | 7 | 248 | 554 | $110,556 | $41,359 |
| 2020 | 7 | 268 | 510 | $102,158 | $37,864 |
Total Patients
794
Total Services
1,700
Medicare Billing
$119,868
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 116 | $23,376 | $7,079 | 30.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 18 | 82 | $7,888 | $3,108 | 39.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 18 | 19 | $6,331 | $2,533 | 40.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 23 | $5,476 | $1,960 | 35.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 117 | $15,444 | $6,354 | 41.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 39 | 40 | $11,449 | $5,470 | 47.8% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 18 | 81 | $26,082 | $5,360 | 20.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 27 | $7,130 | $2,790 | 39.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 35 | 88 | $6,483 | $2,603 | 40.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 27 | 31 | $5,890 | $2,468 | 41.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,136 | $919.68 | 43.1% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 20 | 104 | $33,488 | $8,834 | 26.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 47 | 60 | $17,340 | $8,269 | 47.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 48 | 148 | $19,536 | $8,072 | 41.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 75 | $14,250 | $5,801 | 40.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 45 | 63 | $11,970 | $4,981 | 41.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 29 | 31 | $8,643 | $3,242 | 37.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 38 | 73 | $5,329 | $2,160 | 40.5% |
| 90870 | Shock treatment and monitoring | Facility | 2020 | 16 | 101 | $32,522 | $8,752 | 26.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 43 | 100 | $13,200 | $5,691 | 43.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 49 | 69 | $13,110 | $5,647 | 43.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 46 | 50 | $14,450 | $5,633 | 39.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 64 | $12,160 | $5,272 | 43.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 39 | 39 | $10,365 | $4,235 | 40.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 50 | 87 | $6,351 | $2,633 | 41.5% |
About Dr. Matthew Perry, MD
Dr. Matthew Perry, MD is a Psychiatry healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/19/2011. The National Provider Identifier (NPI) number assigned to this provider is 1689941668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Perry, MD has received a total of $440.60 in payments from pharmaceutical and medical device companies, with $64.26 received in 2020. These payments were reported across 26 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($440.60).
As a Medicare-enrolled provider, Perry has provided services to 794 Medicare beneficiaries, totaling 1,700 services with total Medicare billing of $119,868. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saint Joseph, MO
- Active Since 11/19/2011
- Last Updated 03/15/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1689941668
Products in Payments
- INVEGA SUSTENNA (Drug) $188.85
- ARISTADA (Drug) $144.70
- LATUDA (Drug) $46.14
- ABILIFY MAINTENA (Drug) $29.03
- Aristada 441 mg (Drug) $20.43
- REXULTI (Drug) $11.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Joseph
Dr. Paul Epp, Md, MD
Psychiatry — Payments: $1,783
Psychiatry $1,783
Dr. Donald Hinton, M.d, M.D
Psychiatry — Payments: $801.75
Psychiatry $801.75
Emad Khan, Md, MD
Psychiatry — Payments: $729.90
Psychiatry $729.90
Dr. Alan Anderson, D.o, D.O
Psychiatry — Payments: $556.43
Psychiatry $556.43
Dr. Ali Syed, Do, DO
Psychiatry — Payments: $206.54
Psychiatry $206.54
Richard Lecuru, Md, MD
Psychiatry — Payments: $32.64
Psychiatry $32.64